Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TK-FT (Fentanyl TAIFUN) Pharmacokinetic Study in Cancer Patients
jRCT2080220502Phase 2
- Sponsor
- Teikoku Seiyaku Co., Ltd.
- Start
- Jan 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of fentanyl in cancer pain, breakthrough cancer pain (BTcP) and cancer, sponsored by Teikoku Seiyaku Co., Ltd. Primary endpoint: Primary pharmacokinetic outcomes.
02
Drugs
fentanyl
03
Conditions
cancer painbreakthrough cancer pain (BTcP)cancer
Beyond the preview
Go deeper on jRCT2080220502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220502.